Adjuvant Homoeopathic Management for side effects from chemotherapy in breast cancer patients

Adjuvant Homoeopathic Management for breast cancer patients experiencing side effects from chemotherapy-An observational pilot study

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2011/12/002271

Enrollment

Registered

2011-12-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Side effects of chemotherapy in breast cancer patients

Interventions

Intervention1: Homoeopathic medicines Selection of the medicine will be done after case taking on the basis of presenting totality of symptoms. The prescription shall be justified from Materia Medica

Eligibility

Inclusion criteria

Inclusion criteria: ? Females, 18 years or over, with any stage of any type of breast cancer undergoing chemotherapy ? Patient having any two of the following side effects of chemotherapy viz. nausea, vomiting, abdominal pain, diarrhea, constipation, decreased appetite, hair loss, fatigue reporting within 2 weeks of chemotherapy. ? Patient should not be under Homoeopathic treatment for the side effects of chemotherapy ? Patients able to take self care ? Patients willing to sign written informed consent ? Hb% more than 6.5 gm%

Exclusion criteria

Exclusion criteria: ? Inability to comply with the study protocol, including psychiatric disease ? Features of renal failure (urea more than 50 mg%, creatinine more than 2 mg %) ? Features of gastro intestinal obstruction ? Patients deemed ineligible by the investigator

Design outcomes

Primary

Measure	Time frame
Edmonton Symptom Assessment Scale: Revised Version (ESAS-r)Timepoint: patients will be assessed as per Edmonton Symptom Assessment Scale: Revised Version (ESAS-r)on 3rd and 7th day of homoeopathic treatment after each chemotherapy session. If the patient is not receiving subsequent chemotherapy course, ESES-r is to be filled up every month till 4 months.	—

Secondary

Measure	Time frame
EORTC QLQ-C30 and QLQ-BR23Timepoint: To assess the Health Related Quality of Life: EORTC QLQ-C30 and QLQ-BR23 at 1st and 7th day of homoeopathic treatment after each chemotherapy session. If the patient is not receiving subsequent chemotherapy course, EORTC QLQ-C30 and QLQ-BR23 is to be filled up every month till 4 months.	—

Countries

India

Contacts

Public ContactDr Jaya Gupta

jgupta21@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026